SOBRsafe Reports Triple-Digit Revenue Growth Driven by Strong Demand for SOBRsure GEN 2 Device

SOBRsafe Inc. (NASDAQ: SOBR) reported impressive third-quarter financial results with revenue surging 136.1 percent year over year, driven primarily by strong market adoption of its SOBRsure GEN 2 alcohol detection device. The company's flagship product accounted for more than 80 percent of quarterly revenue, demonstrating significant market traction for its touch-based screening technology. This growth trajectory reflects increasing acceptance of SOBRsafe's innovative approach to alcohol detection, which eliminates the need for traditional breath, blood, or urine samples through advanced transdermal technology.

The company's performance metrics reveal a robust commercial expansion, with 277 devices sold during the quarter and annual recurring software revenue reaching $152.2 thousand, representing a 60.5 percent increase. SOBRsafe's refined marketing strategy contributed to a remarkable 266 percent increase in website traffic, culminating in the company's highest monthly sales recorded in October. This momentum continued into November with the largest single device order in company history, indicating sustained demand for the company's alcohol monitoring solutions across behavioral health, family law, and consumer markets.

Financial performance showed gross profit growing to $37.9 thousand, though operating expenses increased as the company expanded its commercial activities. The net loss widened to $2.2 million as SOBRsafe continues to invest in scaling operations and advancing its technology platform. The company maintained a solid cash position of $4.7 million, providing runway for continued expansion and product development initiatives. These strategic investments are focused on enhancing software capabilities and expanding channel partnerships to support long-term growth objectives.

The company's technology represents a significant advancement in alcohol detection, providing passive, real-time monitoring through skin contact rather than invasive testing methods. This approach offers a more dignified screening solution while maintaining accuracy and reliability. SOBRsafe's backend data platform supports comprehensive monitoring capabilities that serve diverse market segments seeking effective alcohol detection solutions. The strong performance of SOBRsure GEN 2 validates the company's strategic focus on developing next-generation detection technologies that enable trust and empower recovery through innovative, human-centered solutions.

For additional information about the company's technology and solutions, visit https://www.sobrsafe.com. Investors seeking comprehensive financial details and corporate updates can access the full press release and company newsroom through the company's investor relations portal at https://ibn.fm/SOBR.